ALMAC - active and placebo capsule manufacture for the LAMDARCT Clinical Trial
- Published
- 8 December 2025
- Documents
- 1
- Notice number
- 080707-2025
- Reference
- ocds-h6vhtk-058571
- Official source
- Official source
Official publications
- FTS · 080707-2025 · 8 December 2025
Other tenders from Belfast Health and Social Care Trust
- RISDIPLAM 5MG TABLETS, 28 tablets, pack HOMECARE
- SECUKINUMAB 300 mg Pre-filled Injection 1 Pen Pack
- Nemolizumab 30MG PEN (HOMECARE)
- AGALSIDASE ALFA 3.5MG/3.5ML CONCENTRATE FOR SOLUTION FOR INFUSION, 3.5 mL, vial, PACK OF 1 (HOMECARE)
- GIVINOSTAT 8.86MG/ML ORAL SUSPENSION SUGAR-FREE, 140 mL
- Nutritional Products Framework
- United Kingdom Accreditation Service - Provision of Accreditation Services
- Life support Training Course
- Life Support Training Course
- Maintenance of Building Management Systems [6726744]
Frequently asked questions
- Who is the buyer of this tender?
- The contracting authority is Belfast Health and Social Care Trust (United Kingdom).
- How can I bid for public tenders in the United Kingdom?
- Bids are submitted through the official public procurement portal in the United Kingdom. El Vínculo helps you find tenders and analyse their documents; submission always happens at the official source.
Get alerts for tenders like this
Create a free account and receive new public tenders published in the United Kingdom that match your business, every day.
Create a free account and receive new public tenders published in the United Kingdom that match your business, every day.